메뉴 건너뛰기




Volumn 14, Issue 8, 2007, Pages 249-253

Anorexia-cachexia - The condition and its causes

(1)  Mason, Pam a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; NEUROPEPTIDE Y;

EID: 36148937541     PISSN: 13527967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (2)

References (16)
  • 2
    • 0033771667 scopus 로고    scopus 로고
    • Central nervous system mechanisms contributing to the cachexiaanorexia syndrome
    • Plata-Salaman CR. Central nervous system mechanisms contributing to the cachexiaanorexia syndrome. Nutrition 2000;16:1009-12.
    • (2000) Nutrition , vol.16 , pp. 1009-1012
    • Plata-Salaman, C.R.1
  • 3
    • 0030688961 scopus 로고    scopus 로고
    • ABC of palliative care. Anorexia, cachexia, and nutrition
    • Bruera E. ABC of palliative care. Anorexia, cachexia, and nutrition. BMJ 1997;315:1219-22.
    • (1997) BMJ , vol.315 , pp. 1219-1222
    • Bruera, E.1
  • 6
    • 33644824945 scopus 로고    scopus 로고
    • The cancer cachexia syndrome: A review of metabolic and clinical manifestations
    • Esper DH, Harb WA. The cancer cachexia syndrome: a review of metabolic and clinical manifestations. Nutrition in Clinical Practice 2005;20:369-76.
    • (2005) Nutrition in Clinical Practice , vol.20 , pp. 369-376
    • Esper, D.H.1    Harb, W.A.2
  • 7
    • 0033567912 scopus 로고    scopus 로고
    • Cancer anorexia-cachexia syndrome: Are neuropeptides the key?
    • Inui A. Cancer anorexia-cachexia syndrome: are neuropeptides the key? Cancer Research 1999;59:4493-501.
    • (1999) Cancer Research , vol.59 , pp. 4493-4501
    • Inui, A.1
  • 8
  • 9
    • 0031020503 scopus 로고    scopus 로고
    • Cancer cachexia: Metabolic alterations and clinical manifestations
    • Tisdale MJ. Cancer cachexia: metabolic alterations and clinical manifestations. Nutrition 1997;13:1-7.
    • (1997) Nutrition , vol.13 , pp. 1-7
    • Tisdale, M.J.1
  • 10
    • 1942437502 scopus 로고    scopus 로고
    • Role of lipid-mobilising factor (LMF) in protecting tumour cells from oxidative damage
    • Sanders PM, Tisdale MJ. Role of lipid-mobilising factor (LMF) in protecting tumour cells from oxidative damage. British Journal of Cancer 2004;90:1274-8.
    • (2004) British Journal of Cancer , vol.90 , pp. 1274-1278
    • Sanders, P.M.1    Tisdale, M.J.2
  • 16
    • 34250641243 scopus 로고    scopus 로고
    • Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia
    • CD004597
    • Dewey A, Baughan C, Dean T, Higgins B, Johnson I. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database Systematic Review 2007(1):CD004597.
    • (2007) Cochrane Database Systematic Review , Issue.1
    • Dewey, A.1    Baughan, C.2    Dean, T.3    Higgins, B.4    Johnson, I.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.